Entering text into the input field will update the search result below

BSD Medical Corp. (BSDM) Reports on MicroThermX Clinical Evaluations

Jun. 17, 2011 5:58 PM ETPRSN
MissionIR profile picture
MissionIR's Blog
131 Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
BSD Medical Corp. develops, manufacturers, markets, and services systems to treat cancer and benign diseases using heat therapy delivered using focused radio frequency (RF) and microwave energy.
One of the company’s premier line of products is the MicroThermX Microwave Ablation System. It is a compact, mobile, state-of-the-art, proprietary system that includes a microwave generator, single-patent-use disposable antennas and a thermistor-based temperature monitoring system.
The company, on June 16th, reported positive results from the efforts of its sales and distribution network for the MicroThermX Microwave Ablation line of products. At the hospital level, more MicroThermX trained sales representatives are representing the advantages of the MicroThermX to those physicians interested in using a microwave technology platform for tumor ablations.
This increased sales activity has resulted in a full schedule of clinical evaluations in the coming weeks. These evaluations represent an important milestone in the MicroThermX sales cycle, with hospital capital budgeting, committee review and other approvals required to complete the sales cycle.
The company is excited by the initial sales from the rollout of its sales and marketing strategy. It also points to the medical facilities where BSD initially placed the systems and the reorders of the disposable microwave antennas as a positive indicator of its potential ongoing revenue stream.
For additional information on BSD Medical, please visit its website at BSDmedical.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You